IONIS PHARMACEUTICALS INC Insider Trading for November 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IONIS PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IONIS PHARMACEUTICALS INC for November 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 11.27 | 2,500 | 28,175 | 2,500 | |
| Nov 16 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 47.50 | 2,500 | 118,750 | 6,548 | 9 K to 6.5 K (-27.63 %) |
| Nov 16 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 11.27 | 2,500 | 28,175 | 9,048 | 6.5 K to 9 K (+38.18 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 806 | 8,721 | 2,694 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Option Exercise | M | 10.82 | 194 | 2,099 | 4,907 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 806 | 36,270 | 9,526 | 10.3 K to 9.5 K (-7.80 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 806 | 8,721 | 10,332 | 9.5 K to 10.3 K (+8.46 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Sell | S | 45.00 | 194 | 8,730 | 9,526 | 9.7 K to 9.5 K (-2.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | O'NEIL PATRICK R. | SVP, Legal & Genera ... | Buy | M | 10.82 | 194 | 2,099 | 9,720 | 9.5 K to 9.7 K (+2.04 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 11.27 | 2,500 | 28,175 | 5,000 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Option Exercise | M | 11.27 | 2,500 | 28,175 | 7,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 41.00 | 2,500 | 102,500 | 6,548 | 9 K to 6.5 K (-27.63 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 11.27 | 2,500 | 28,175 | 9,048 | 6.5 K to 9 K (+38.18 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Sell | S | 38.49 | 2,500 | 96,225 | 6,548 | 9 K to 6.5 K (-27.63 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | HOUGEN ELIZABETH L | SVP, Finance & CFO | Buy | M | 11.27 | 2,500 | 28,175 | 9,048 | 6.5 K to 9 K (+38.18 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 1,000 | 10,290 | 5,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 10,000 | 72,500 | 93,462 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 2,000 | 20,580 | 6,500 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 7.25 | 3,741 | 27,122 | 103,462 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Option Exercise | M | 10.29 | 16,259 | 167,305 | 0 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 42.22 | 1,000 | 42,220 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 40.23 | 10,000 | 402,300 | 25,029 | 35 K to 25 K (-28.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 10,000 | 72,500 | 35,029 | 25 K to 35 K (+39.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.25 | 1,000 | 37,250 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.10 | 1,000 | 35,100 | 2,170 | 3.2 K to 2.2 K (-31.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 1,000 | 10,290 | 3,170 | 2.2 K to 3.2 K (+46.08 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.50 | 3,741 | 140,288 | 25,029 | 28.8 K to 25 K (-13.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 7.25 | 3,741 | 27,122 | 28,770 | 25 K to 28.8 K (+14.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 37.10 | 6,259 | 232,209 | 25,029 | 31.3 K to 25 K (-20.00 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 6,259 | 64,405 | 31,288 | 25 K to 31.3 K (+25.01 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Sell | S | 35.55 | 10,000 | 355,500 | 25,029 | 35 K to 25 K (-28.55 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | CROOKE STANLEY T | Chairman and CEO | Buy | M | 10.29 | 10,000 | 102,900 | 35,029 | 25 K to 35 K (+39.95 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 11.27 | 22,805 | 257,012 | 0 | |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 38.54 | 17,805 | 686,205 | 10,803 | 28.6 K to 10.8 K (-62.24 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 11.27 | 17,805 | 200,662 | 28,608 | 10.8 K to 28.6 K (+164.82 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 34.08 | 5,000 | 170,400 | 10,803 | 15.8 K to 10.8 K (-31.64 %) |
| Nov 14 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 11.27 | 5,000 | 56,350 | 15,803 | 10.8 K to 15.8 K (+46.28 %) |
| Nov 09 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Option Exercise | M | 11.27 | 5,000 | 56,350 | 22,805 | |
| Nov 09 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Sell | S | 34.00 | 5,000 | 170,000 | 10,803 | 15.8 K to 10.8 K (-31.64 %) |
| Nov 09 2016 | ISIS | IONIS PHARMACEUTIC ... | BENNETT C FRANK | SVP, Antisense Rese ... | Buy | M | 11.27 | 5,000 | 56,350 | 15,803 | 10.8 K to 15.8 K (+46.28 %) |